- Home
- Our Services
- Medical Device & IVD
- Russia Medical Device Registration
Our Services
Medical Device Registration in Russia
Medical device registration in Russia is managed by Roszdravnadzor (RZN) — the Federal Service for Health Oversight. Every medical device sold in Russia must hold a valid RZN Registration Certificate before it can be legally marketed or distributed. Devices are classified into 4 risk classes (I, IIa, IIb, III). The process involves technical documentation, local lab testing, clinical evaluation, and for Class IIb/III devices, a mandatory manufacturing site inspection. Timeline ranges from 5 working days (Class I, fast-track) to up to 2 years (Class III). From January 1, 2027, new registrations will only be accepted under the EAEU (Eurasian Economic Union) pathway. Companies entering the Russian market today need an authorized local representative (RUS REP) and a Russia-compliant technical dossier. Traccglobal helps global manufacturers navigate this entire process — from dossier preparation to RZN certificate issuance.
Why Russia? Understanding the Market Opportunity
Russia is one of the largest medical device markets in the world, with a population of over 144 million and a rapidly expanding healthcare infrastructure. The Russian government has been actively increasing public health spending, driving strong demand for diagnostic equipment, surgical instruments, implantables, and in-vitro diagnostics (IVDs).
For foreign manufacturers — especially those already certified in the EU (CE marking) or the US (FDA 510k) — Russia presents a significant market entry opportunity. However, Russia’s regulatory framework is independent, complex, and frequently updated. Unlike many markets that accept CE or FDA certificates at face value, Russia requires its own domestic registration before any medical device can be legally sold or distributed.
If you are a manufacturer looking to enter Russia, the first question you will face is: How does medical device registration in Russia actually work? This guide answers that question in full — without the jargon.
Who Regulates Medical Devices in Russia?
The regulatory body for medical device registration in Russia is Roszdravnadzor (Federal Service for Surveillance in Healthcare), which operates under the Russian Ministry of Health. It is also referred to as RZN.
The foundational legal basis for medical devices in Russia is Article 38 of Federal Law No. 323 (the Health Law). This law defines what constitutes a medical device, establishes mandatory registration requirements, and sets the framework for market surveillance and enforcement.
Within Roszdravnadzor, the Medical Device Registration and Control Department handles all registration approvals, denials, modifications, and cancellations. Three expert institutions called FGBUs (Federal State Budgetary Institutions) support Roszdravnadzor in the scientific review of dossiers. The most important of these is the National Institute of Quality (FGBU NMIC).
Working with Roszdravnadzor requires strong knowledge of Russian regulatory language, documentation norms, and the unwritten expectations of reviewers — which is exactly where an experienced consultant adds the most value.
Two Registration Routes Available in Russia (2026)
One of the most important things to understand in 2026 is that Russia now offers — and will soon mandate — two distinct registration pathways:
1. National Registration (Valid Only in Russia)
This is the traditional Roszdravnadzor registration under Government Decree No. 1684 (effective from March 1, 2025, replacing the earlier Decree No. 1416 of 2012). The resulting RZN Registration Certificate is valid indefinitely and covers the Russian market only.
2. EAEU (Eurasian Economic Union) Sovereign Registration
The EAEU registration is valid across all five member states: Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan. This makes it strategically more valuable — one registration, five markets.
Under the EAEU pathway, the manufacturer selects a Reference State and submits a joint technical dossier. Tests and clinical investigations can be conducted in any EAEU member state (not just Russia), which reduces costs and timelines for some product categories.
Critical 2026 Update: From January 1, 2027, new device registrations will only be accepted through the EAEU system. National-only registrations will no longer be available for new applicants after this date. Existing national certificates remain valid, but any new market entry after January 2027 must follow the EAEU pathway.
If you are planning market entry today, our team strongly recommends planning for EAEU registration — not just Russia — to future-proof your investment and maximize market access.
Medical Device Classification in Russia
Russia uses a 4-class risk-based classification system, harmonized with the European EEC Directive 93/42:
Note: For Class A Non-Sterile, Non-Measuring devices, a simplified registration is available instead of a full manufacturing license. Your consultant at Traccglobal will confirm the exact pathway for your product.
| Risk Class | Risk Level | Examples | Registration Complexity |
|---|---|---|---|
| Class I (Non-Sterile) | Lowest risk | Bandages, manual instruments, tongue depressors | Simplified / fast-track available |
| Class IIa | Low-moderate risk | Ultrasound gel, ECG electrodes, blood pressure cuffs | Standard multi-stage |
| Class IIb (Sterile) | Moderate-high risk | Infusion pumps, ventilators | Full review + site inspection (from 2024) |
| Class III | Highest risk | Implantable pacemakers, coronary stents, spinal implants | Full review + clinical + site inspection |
Classification is determined by the CND RUS code (National Classification of Medical Devices), governed by Ministry of Health Decree No. 4n. Each registration certificate is issued against a single CND RUS code, a single risk class, and specific supply conditions (sterile vs. non-sterile).
Russia also has its own set of product-specific standards known as GOSTs — GOST R for national standards and GOST ISO for standards aligned with international norms. Depending on your device type, one or more GOST standards may apply in addition to the main registration requirements. Our regulatory team identifies applicable GOSTs for your product category as part of the initial strategy review.
Important: Getting the classification right from the start matters enormously. Misclassification leads to rejection, wasted time, and restarting the entire dossier process. Our regulatory team reviews your device’s intended use, clinical function, and Russian nomenclature before you invest in a single document.
Medical Device Registration Process: Step by Step
Step 1 — Appoint an Authorized Russian Representative (RUS REP)
Foreign manufacturers cannot apply directly to Roszdravnadzor. You must appoint a Russian Authorized Representative (RUS REP) who is based in Russia and assumes legal responsibility for the device throughout its life cycle — from registration through post-market surveillance.
The RUS REP’s details appear on the registration certificate. Choosing the right RUS REP is critical — they are your regulatory anchor in Russia.
Step 2 — Prepare the Technical Dossier
The technical dossier must comply with Ministerial Ordinance No. 11 (Technical and User Documentation Requirements). It includes:
- Administrative documentation and power of attorney (with Apostille)
- Product description, technical specifications, drawings, and diagrams
- Description of raw materials and manufacturing process
- Stability and sterility reports (where applicable)
- Biocompatibility testing based on ISO 10993
- IEC 60601 certificates (for active medical devices)
- ISO 13485:2016 certificate (mandatory for Class IIa sterile, IIb, and III devices)
- Labels and Instructions for Use (IFU) in Russian
- Clinical evaluation data
- Free sale certificate from the country of origin
- Applicable GOST compliance documentation (device-specific)
All documents must be translated into Russian by a certified translator. Public documents and certificates must carry an Apostille stamp.
Step 3 — Submit the Application to Roszdravnadzor
The registration application is submitted formally to Roszdravnadzor in Moscow. This initiates the formal phase of review.
Step 4 — Formal Assessment (Phase 1)
Roszdravnadzor checks whether the dossier is complete and conforms to documentation requirements. The dossier is then passed to the FGBU National Institute of Quality for expert review. If clinical investigation is deemed necessary, the process enters a hold phase while the manufacturer carries it out.
Step 5 — Clinical Investigation (Where Required)
For innovative devices that have no registered equivalent in Russia, a clinical investigation must be conducted in Russian clinical centers, following approval by the National Ethics Committee. For Class I and IIa devices with existing clinical documentation, this step may be waived.
For Class IIa sterile, IIb, and III devices: manufacturing site inspection by Russian authorities became mandatory from January 1, 2024. This is a significant change that adds both time and cost for manufacturers in these classes.
Step 6 — Substantial Assessment (Phase 2)
After clinical data is submitted, the FGBU conducts a second expert review. If the outcome is positive, Roszdravnadzor issues the RZN Registration Certificate and adds the device to the official Russian medical device database.
Step 7 — Certificate Issuance
The RZN Registration Certificate is issued and is valid for an indefinite period — it does not expire unless suspended or cancelled due to safety issues or regulatory changes. This is a significant advantage over markets where certificates must be periodically renewed.
Medical Device Registration Timelines (2026)
| Registration Pathway | Timeframe |
|---|---|
| Class I (fast-track, Government Decree No. 552 — sanction-impact devices) | 5 working days |
| Class I (standard single-stage) | 6–8 months |
| Class IIa, IIb, III (multi-stage) | Up to 2 years |
| Administrative updates (holder change, RUS REP change, trademark) | 15 working days |
| Substantial changes requiring re-examination | Up to 3 months |
Note: These are regulatory timelines from the date of complete submission. They do not include time needed to prepare documents and conduct lab testing.
Government Fees for Medical Device Registration (2026)
| Fee Item | Amount |
|---|---|
| Certificate issuance | 11,000 RUB (~€110) |
| Certificate update or replacement | 2,500 RUB (~€25) |
| Conformity assessment — Class I | 72,000 RUB (~€720) |
| Conformity assessment — Class IIa | 104,000 RUB (~€1,040) |
| Conformity assessment — Class IIb | 136,000 RUB (~€1,360) |
| Conformity assessment — Class III | 184,000 RUB (~€1,840) |
| Manufacturing site audit (Class IIa sterile, IIb, III) | Up to 3,069,000 RUB (~€31,200) |
These government fees do not include costs for lab testing (biocompatibility, EMC, safety), clinical investigation, translation, dossier preparation, or consultant fees. We provide a complete cost estimate before you commit to the process.
What Documents Do You Need?
Here is the core document checklist for registering your medical device with Roszdravnadzor:
- Power of Attorney with Apostille stamp (from foreign manufacturer to RUS REP)
- Technical documentation per EU MDR Regulation 2017/745 Annex II (adapted for Russian requirements)
- ISO 13485:2016 Certificate (mandatory for Class IIa sterile, IIb, III)
- Free Sale Certificate from the country of origin
- Manufacturer’s license for manufacture in the country of origin
- Biocompatibility study reports (ISO 10993)
- IEC 60601 safety testing certificates (for active devices)
- Clinical evaluation report (or clinical investigation data)
- Instructions for Use (IFU) in Russian
- Labelling compliant with Russian CND RUS code requirements
- Device samples (for physical testing in Russian labs)
- Manufacturing process description
- Quality Manual / QMS overview
- Applicable GOST standard compliance documentation (device-specific)
All documents must be translated into Russian by a certified translator. Documents from EU countries must carry an Apostille stamp.
Important 2026 Regulatory Update: Decree No. 1684
In November 2024, Russia published Government Decree No. 1684 which replaced the longstanding Decree No. 1416 (in force since 2012). The new Decree became effective on March 1, 2025, and introduces several important changes:
- Updated documentation requirements that align more closely with EAEU standards
- Revised procedures for manufacturing site inspections (mandatory for Class IIa sterile, IIb, III from January 2024)
- Clearer rules for fast-track registration of sanction-impacted devices
- Strengthened post-market surveillance obligations
Manufacturers who prepared dossiers under Decree No. 1416 may need to update their documentation to comply with Decree No. 1684. Our team stays current with every regulatory update — so your dossier is always compliant from day one.
VAT Exemption: A Compliance Advantage Worth Knowing
This is one detail that most guides do not mention — but it has real financial value for importers and distributors.
Correctly classifying your medical device and completing registration under the right CND RUS code may entitle your product to:
- Full VAT exemption under Russian Government Decree No. 1042 (for essential medical devices)
- Partial VAT exemption under Decree No. 688
VAT in Russia is 20% on standard products. A full exemption significantly reduces the landed cost of your device and makes it more competitive in tenders and hospital procurement. Getting the classification right from the beginning — not just for safety, but for tax purposes — is something our team specifically addresses in the regulatory strategy for every client.
Real Case Studies: How Our Clients Entered Russia
Case Study 1: German Class III Cardiac Device Manufacturer — Full Registration in 18 Months
A German manufacturer of implantable cardiac rhythm management devices (Class III) needed support for their Russia market entry. Their CE-certified dossier was strong, but the clinical data format did not align with Roszdravnadzor requirements. Additionally, they had no existing relationships with Russian clinical investigation centers.
Our team reformatted the clinical evaluation, identified accredited Russian clinical centers, coordinated the Ethics Committee approval, and appointed a qualified RUS REP. The entire process — from initial engagement to RZN certificate — was completed in 18 months, which is 25% faster than the typical Class III timeline.
Outcome: The manufacturer secured distribution agreements with three major Russian hospital chains within 6 months of certificate issuance.
Case Study 2: Indian IVD Diagnostic Kit Manufacturer — EAEU Registration for 5 Markets
An Indian manufacturer of Class IIa immunoassay diagnostic kits wanted to enter Russia, Kazakhstan, and Belarus simultaneously. Rather than pursuing three separate national registrations, we recommended the EAEU Sovereign Registration pathway with Russia as the Reference State.
This single registration process — covering all five EAEU member states — was completed in 22 months. The cost was 40% lower than pursuing three separate national registrations would have been.
Outcome: The manufacturer now sells in all five EAEU markets under a single registration certificate, with annual revenues from the EAEU region exceeding ₹4.5 crore.
Case Study 3: UK Orthopaedic Implant Company — Fast-Track Class I Registration
A UK-based manufacturer of Class I non-sterile orthopaedic instruments (surgical clamps, retractors, bone rasps) needed to register their product range in Russia quickly due to a distributor agreement deadline.
Our team confirmed eligibility for the fast-track sanction-impact pathway under Decree No. 552. The 5-day provisional certificate was obtained, with the full dossier completed within the 6-month window. The distributor relationship was secured without delay.
Outcome: 12 individual product lines registered within 4 months of full engagement. Distributor contract signed. Products now available through Russian hospital procurement channels.
Common Mistakes That Delay Russia Registration
Most delays in medical device registration in Russia come from the same predictable sources. Here is what to avoid:
1. Incomplete or incorrectly formatted documents Roszdravnadzor is very specific about document format, stamp requirements, and translation quality. A single missing Apostille or a translation error can stall the process for months.
2. Wrong CND RUS code selection Russia’s classification nomenclature is different from EU or FDA classification. Assigning the wrong CND RUS code delays the formal assessment phase and may require restarting from scratch.
3. Underestimating clinical investigation requirements Many manufacturers assume their CE-certified clinical data is sufficient. Russia has its own clinical evaluation standards. Data accepted by a European Notified Body may need supplementation or reformatting for Roszdravnadzor.
4. Ignoring the EAEU transition Applying for national-only registration in 2026 without considering the EAEU pathway is a strategic mistake. From January 2027, all new submissions must follow the EAEU route — meaning double the cost and time if you plan incorrectly.
5. Appointing an unqualified RUS REP Your RUS REP is legally accountable for your device in Russia. Appointing someone without proper qualifications or experience creates regulatory risk throughout your device’s market life.
Our end-to-end Russia registration service is designed to eliminate each of these risks before they cost you time and money.
Why Choose Traccglobal for Russia Medical Device Registration?
At Traccglobal, we combine deep knowledge of Russian regulatory requirements with hands-on experience managing complex cross-border registrations for manufacturers from India, Europe, the UK, and the US.
Here is what we do differently:
| What We Provide | What It Means For You |
|---|---|
| Full dossier preparation (Russia-format) | No translation errors, no missing Apostilles, no rejection risk |
| RUS REP appointment support | Legal accountability managed properly from day one |
| Russia-specific clinical evaluation review | Your CE or FDA data adapted to Roszdravnadzor standards |
| Local lab coordination | Testing in accredited Russian facilities without you managing it |
| EAEU registration strategy | Five-market access with one optimized registration pathway |
| Real-time application tracking | You always know exactly where your registration stands |
| Post-market compliance support | Adverse event reporting, label updates, certificate modifications |
| VAT exemption classification advisory | Maximize your commercial advantage at no extra registration cost |
| GOST compliance review | Identify all applicable Russian product standards before submission |
We are not a generic regulatory firm. Our team has specific, documented experience with Roszdravnadzor submissions, EAEU reference state processes, Russian clinical investigation coordination, and the documentation standards that Decree No. 1684 now requires.
If you want to enter the Russian medical device market — or the broader EAEU region — without delays, rejections, or costly mistakes, Traccglobal is the partner you need.
Frequently Asked Questions (FAQ) - Russia Medical Device Registration
Q1. Is CE marking accepted in Russia instead of local registration?
No. Russia does not accept CE marking as a substitute for Roszdravnadzor registration. Every device must go through the full Russian registration process, regardless of existing EU or FDA approvals. CE data can support your Russian clinical evaluation but does not replace it.
Q2. How long is the RZN Registration Certificate valid?
The RZN Registration Certificate is valid for an indefinite period — it does not expire. However, it can be suspended or cancelled if the device is modified, if post-market safety issues arise, or if regulatory requirements change materially.
Q3. Can the RZN certificate be transferred if the manufacturer or RUS REP changes?
Yes, but this requires an administrative update submission to Roszdravnadzor. Timeline for administrative updates is approximately 15 working days.
Q4. What happens to existing national registrations after January 2027?
Existing national RZN certificates issued before January 1, 2027 remain valid. However, no new national-only registrations will be accepted after this date. All new submissions must follow the EAEU pathway.
Q5. Does Russia require local lab testing even if I have ISO-certified results from my home country?
Yes. For most device classes, Russia requires testing in locally accredited laboratories and health facilities. Existing ISO 10993 or IEC 60601 data may support the dossier, but Russian local tests are typically still required.
Q6. What is the difference between a RUS REP and a local distributor?
A RUS REP (Russian Authorized Representative) is a regulatory appointment — they are legally responsible for your device’s compliance with Russian law. A distributor handles commercial sales. They can be the same entity or different ones. Our team can help you structure this correctly for your market entry model.
Q7. How much does the Russia registration process cost in total?
Government fees are relatively modest (see the fee table above). The main costs are dossier preparation, Russian lab testing, clinical investigation (if required), site inspection fees (for Class IIa sterile, IIb, III), translation, and consultant fees. We provide a detailed project-specific cost estimate before engagement — so there are no surprises.
Q8. Can you help with both Russia national registration and EAEU registration?
Yes. We manage both pathways and can advise on which route is most efficient for your device class, target markets, and timeline. Contact us for a free consultation.
Our Services
Let Us Know Your Requirements
Call Emergency
+918868886774
What Our Clients Says
Real feedback from our happy clients about our quality and service.
